10.10.2016
- As part of a “broader, global strategic plan” to centralize control over its drug discovery programs and contain costs, Swiss drugmaker Novartis said it will close R&D sites in...
29.09.2016
- Handling global exports in compliance with GDP and distributing temperature-sensitive, high-priced drugs throughout Europe is a major challenge. Along with the need to meet...
14.08.2016
- AstraZeneca has invested another $140 million in US biotech concern Moderna Therapeutics. The new investment is part of a preferred-stock financing and lifts its stake in Moderna...
21.07.2016
- In presenting the company’s financial results for the second quarter of 2016, Joe Jimenez, CEO of Swiss drugmaker Novartis, took the opportunity to add comment on crucial issues...
19.07.2016
- Bayer and X-Chem Pharmaceuticals have expanded their global drug discovery collaboration, which was launched in 2012 and spans multiple therapeutic areas and target classes. The...
12.07.2016
- The UK pharmaceutical industry and government officials have established a task force to address regulatory concerns and other top issues facing the pharmaceutical sector as the...
08.07.2016
- Within the course of a week, US-based KaloBios Pharmaceuticals has emerged from Chapter 11 bankruptcy protection, renegotiated a deal to acquire rights to a new developmental drug...
29.06.2016
- Singapore palm oil company Musim Mas has agreed to buy Dutch Glycerin Refinery (DGR) for an undisclosed sum. Wholly owned subsidiary Musim Mas Europe will acquire the company that...
